SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Envision Healthcare Corporation (NYSE: EVHC) To Contact Brower Piven Before The Lead Plaintiff Deadlin

STEVENSON, Md., Aug. 07, 2017 -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Middle District of Tennessee on behalf of purchasers of Envision Healthcare Corporation (NYSE:EVHC) (“Envision” or the “Company”) securities during the period between March 2, 2015 and July 21, 2017, inclusive (the “Class Period”).  Investors who wish to become proactively involved in the litigation have until October 3, 2017 to seek appointment as lead plaintiff.

If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court.  The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action.  The lead plaintiff will be selected from among applicants claiming the largest loss from investment in Envision securities during the Class Period.  Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff.  No class has yet been certified in the above action.

The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants’ failure to disclose during the Class Period that Envision’s operating subsidiary, EmCare Holdings, Inc. (“EmCare”), routinely arranged for patients who sought treatment at in-network facilities to be treated by out-of-network physicians, EmCare accordingly billed these patients at higher rates than if the patients had received treatment from in-network physicians, and EmCare revenues were likely to be unsustainable after the conduct came to light.

According to the complaint, following a July 24, 2017 article about the billing practices, the value of Envision shares declined significantly.

If you have suffered a loss in excess of $100,000 from investment in Envision securities purchased on or after March 2, 2015 and held through the revelation of negative information during and/or at the end of the Class Period and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or obligation to you, please visit our website at http://www.browerpiven.com/currentsecuritiescases.html.  You may also request more information by contacting Brower Piven either by email at [email protected] or by telephone at (410) 415-6616.

Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s.  If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice.  You need take no action at this time to be a member of the class. 

CONTACT:  Charles J. Piven
Brower Piven, A Professional Corporation
1925 Old Valley Road
Stevenson, Maryland 21153
Telephone: 410-415-6616
[email protected]